CYCLOSPORINE A AND SIGNAL TRANSDUCTION
环孢菌素 A 和信号转导
基本信息
- 批准号:3140219
- 负责人:
- 金额:$ 17.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-07-01 至 1991-06-30
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte T lymphocyte biological signal transduction cell membrane cyclosporines drug resistance enzyme induction /repression fluorescent dye /probe immunofluorescence technique laboratory mouse leukocyte activation /transformation lipid metabolism membrane lipids membrane potentials neoplastic cell phosphatidylinositols phosphorylation pleiotropism protein kinase C tissue /cell culture
项目摘要
Pleiotropic drug resistance is characterized by alterations in cell
membrane properties. It has been shown that certain
chemotherapeutic agents exert antineoplastic effect at the level
of membrane. Cyclosporine A (CsA) partitions into phospholipid
vesicles and interferes with plasma membrane phospholipid
metabolism. It has also been shown to decrease the motional
freedom of membrane lipids and to depolarize plasma membrane
potentials in murine lymphoctyes. The overall aim of this
proposal is to understand the effects of CsA on signal
transduction pathway using both neoplastic (sensitive and
pleiotropic drug resistant) and normal T and EBV-induced B cell
lines. The specific aims of the study are: (1) To compare plasma
membrane potentials in sensitive T and B leukemia cell lines and
their corresponding drug resistant sublines, and in T and B cells
lines derived from normal lymphocytes. The membrane potentials
will be studied with DiOC5 dye using FACS. (2) To examine the
effect of CsA on the generation of inositol trisphosphate in
resistant and sensitive leukemic cell lines and T and B cell lines
derived from normal lymphocytes. (3) To study the in vitro direct
effect of CsA on the activation and translocation of protein
kinase C (PKC) in tumor and normal lymphocyte-derived T and B
cells lines. Studies will also be done to examine regulatory role of
CsA on PMA-induced activation and translocation will be
measured by immunoprecipitation and indirect
immunofluorescence, using an alloantibody against PKC. (4) To
examine the effect of CsA on membrane phosphorylation of P-
180. The studied would help in the understanding of the
mechanisms of CsA on the early steps of lymphocyte activation
and the mechanisms by which CsA corrects the pleiotropic drug
resistance in neoplastic cells.
多效性耐药的特征是细胞的改变
膜特性。已经证明,某些人
化疗药物在一定水平上发挥抗肿瘤作用
膜的作用。环孢素A(CsA)在磷脂中的分配
囊泡和对质膜磷脂的干扰
新陈代谢。它也被证明可以减少运动
膜脂自由与质膜去极化
小鼠淋巴细胞学的潜能。这样做的总体目标是
建议了解CSA对信号的影响
使用肿瘤的转导途径(敏感和
多效性耐药)和正常T细胞和EB病毒诱导的B细胞
台词。研究的具体目的是:(1)比较血浆
敏感的T和B白血病细胞系的膜电位和
其相应的耐药亚系,以及在T和B细胞
来源于正常淋巴细胞的线条。膜电位
将用DiOC5染料进行流式细胞仪研究。(2)审查
环孢素A对细胞内三磷酸肌醇生成的影响
耐药和敏感的白血病细胞系和T、B细胞系
来源于正常的淋巴细胞。(3)体外直接研究
环孢素A对蛋白质激活和转位的影响
肿瘤和正常淋巴细胞来源的T、B细胞中的蛋白激酶C
细胞系。还将进行研究,以审查监管作用
CsA对PMA诱导的激活和易位的影响
通过免疫沉淀和间接测定
免疫荧光,使用PKC同种异体抗体。(4)至
环孢素A对P-半胱氨酸膜磷酸化的影响
180.所研究的将有助于理解
环孢素A在淋巴细胞活化早期的作用机制
以及CsA纠正多效性药物的机制
肿瘤细胞中的耐药性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUDHIR GUPTA其他文献
SUDHIR GUPTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUDHIR GUPTA', 18)}}的其他基金
TNF-Induced Apoptosis of Lymphocytes in Aged Humans
TNF 诱导的老年人淋巴细胞凋亡
- 批准号:
6624500 - 财政年份:2002
- 资助金额:
$ 17.45万 - 项目类别:
TNF-Induced Apoptosis of Lymphocytes in Aged Humans
TNF 诱导的老年人淋巴细胞凋亡
- 批准号:
6475385 - 财政年份:2002
- 资助金额:
$ 17.45万 - 项目类别:
TNF-Induced Apoptosis of Lymphocytes in Aged Humans
TNF 诱导的老年人淋巴细胞凋亡
- 批准号:
6747896 - 财政年份:2002
- 资助金额:
$ 17.45万 - 项目类别:
CONFERENCE ON LYMPHOCYTE ACTIVATION & IMMUNOREGULATION
淋巴细胞激活会议
- 批准号:
3433564 - 财政年份:1990
- 资助金额:
$ 17.45万 - 项目类别:
CONFERENCE ON LYMPHOCYTE ACTIVATION/IMMUNE REGULATION
淋巴细胞激活/免疫调节会议
- 批准号:
3433506 - 财政年份:1987
- 资助金额:
$ 17.45万 - 项目类别:
CONFERENCE ON LYMPHOCYTE ACTIVATION/IMMUNE REGULATION
淋巴细胞激活/免疫调节会议
- 批准号:
3433507 - 财政年份:1987
- 资助金额:
$ 17.45万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 17.45万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 17.45万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 17.45万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 17.45万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 17.45万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 17.45万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 17.45万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 17.45万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 17.45万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 17.45万 - 项目类别:
Discovery Grants Program - Individual